Compare Heron Therapeutics Inc (HRTX) vs Quanta Services Inc (PWR) Price & Performance

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

PWR trades at $633.04, up 0.72% today, with strong analyst support (27 Buy, 0 Sell) and a consensus price target of $836.80. Recent quarters show consistent EPS beats, with Q1 2026 actual of $2.68 exceeding the $2.04 estimate. Revenue growth is robust, climbing from $17.1B in 2022 to $28.5B in 2025, though net margins remain modest at 3.67%. Technical indicators are mixed, with a bearish overall signal but bullish oscillators like RSI near oversold levels.

The outlook is positive due to infrastructure demand from AI and grid modernization, with a projected $2.4T addressable market by 2030. Risks include high valuation multiples (P/E 86.22) and aggressive capital spending impacting cash flow. Institutional sentiment is bullish, but execution risks and economic cycles could pressure near-term performance.